bio sketch column
Daniel Price, PhD, is a senior scientist in computational chemistry at GlaxoSmithKline with a broad background in structure- and ligand-based design, theoretical physical chemistry, programming, and methods for integrating and analyzing information at the intersection of chemistry and biology. In addition to contributions to multiple clinical candidates and program leadership, he has had a keen interest in integrating diverse information sources that enable the identification and use of chemical probes in target validation, drug repurposing, investigative toxicology, phenotypic screening, and the understanding of the structural determinants of selectivity. Before joining GSK, he received his BS in Chemical Engineering from the University of Colorado, Boulder and completed his PhD in Molecular Biophysics and Biochemistry at Yale University. He subsequently performed postdoctoral research in the Department of Molecular Biology at the Scripps Research Institute.